Immunohistochemical Evaluation of MET
Corresponding Organization : Northwestern University
Other organizations : Jiangsu Province Hospital, Central South University, Hunan Cancer Hospital
Variable analysis
- MET immunohistochemical staining (MET-IHC) evaluation
- Percentage of cells showing weak (1+), moderate (2+), or strong (3+) membranous staining
- MET overexpression (considered positive if ≥ 50% of tumor cells showing cellular membrane staining at an intensity of '2+' or '3+')
- Benchmark Ultra Autostainer (Ventana, Tucson, AZ)
- Anti-total c-MET (SP44) rabbit monoclonal primary antibody (Ventana, Tucson, AZ)
- Scoring performed independently by two individuals, with discrepant cases re-evaluated for final interpretation
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!